Bangalore, S., Maron, D., O'Brien, S., Fleg, J., Kretov, E., Briguori, C., Kaul, U., Reynolds, H., Mazurek, T., Sidhu, M., Berger, J., Mathew, R., Bockeria, O., Broderick, S., Pracon, R., Herzog, C., Huang, Z., Stone, G., Boden, W., Newman, J., Ali, Z., Mark, D., Spertus, J., Alexander, K., Chaitman, B., Chertow, G., Hochman, J. and , J.T.N.E.j.o.m., 2020. Management of Coronary Disease in Patients with Advanced Kidney Disease. 382, 1608-1618.
Belch, J., Bridges, A., Scott, N. and Chopra, M.J.B.h.j., 1991. Oxygen free radicals and congestive heart failure. 65, 245-8.
Bertero, E. and Maack, C.J.N.r.C., 2018. Metabolic remodelling in heart failure. 15, 457-470.
Chen, S., Zhang, Y., Lighthouse, J., Mickelsen, D., Wu, J., Yao, P., Small, E. and Yan, C.J.C., 2020a. A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction. 141, 217-233.
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., Wang, T., Guo, W., Chen, J., Ding, C., Zhang, X., Huang, J., Han, M., Li, S., Luo, X., Zhao, J. and Ning, Q.J.B., 2020b. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. 368, m1091.
Chen, X., Gan, Q., Feng, C., Liu, X., Zhang, Q.J.J.o.c.i. and modeling, 2018. Virtual Screening of Novel and Selective Inhibitors of Protein Tyrosine Phosphatase 1B over T-Cell Protein Tyrosine Phosphatase Using a Bidentate Inhibition Strategy. 58, 837-847.
Cheng, S., Quintin, J., Cramer, R., Shepardson, K., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E., Martens, J., Rao, N., Aghajanirefah, A., Manjeri, G., Li, Y., Ifrim, D., Arts, R., van der Veer, B., van der Meer, B., Deen, P., Logie, C., O'Neill, L., Willems, P., van de Veerdonk, F., van der Meer, J., Ng, A., Joosten, L., Wijmenga, C., Stunnenberg, H., Xavier, R. and Netea, M.J.S., 2014. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. 345, 1250684.
Chevallier, V., Andersen, M., Malphettes, L.J.B. and bioengineering, 2020. Oxidative stress-alleviating strategies to improve recombinant protein production in CHO cells. 117, 1172-1186.
Chirinos, J., Zhao, L., Jia, Y., Frej, C., Adamo, L., Mann, D., Shewale, S., Millar, J., Rader, D., French, B., Brandimarto, J., Margulies, K., Parks, J., Wang, Z., Seiffert, D., Fang, J., Sweitzer, N., Chistoffersen, C., Dahlbäck, B., Car, B., Gordon, D., Cappola, T. and Javaheri, A.J.C., 2020. Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure. 141, 1463-1476.
Cifani, P. and Kentsis, A.J.P., 2017. Towards comprehensive and quantitative proteomics for diagnosis and therapy of human disease. 17.
Connell, P., Word, T. and Wehrens, X.J.E.o.o.t.t., 2020. Targeting pathological leak of ryanodine receptors: preclinical progress and the potential impact on treatments for cardiac arrhythmias and heart failure. 24, 25-36.
Cramer, S., Saha, A., Liu, J., Tadi, S., Tiziani, S., Yan, W., Triplett, K., Lamb, C., Alters, S., Rowlinson, S., Zhang, Y., Keating, M., Huang, P., DiGiovanni, J., Georgiou, G. and Stone, E.J.N.m., 2017. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. 23, 120-127.
Dong, Z., Zhao, P., Xu, M., Zhang, C., Guo, W., Chen, H., Tian, J., Wei, H., Lu, R. and Cao, T.J.S.r., 2017. Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation. 7, 2691.
Eisenberg, E., Di Palo, K. and Piña, I.J.C.c., 2018. Sex differences in heart failure. 41, 211-216.
Fu, H., Sanada, S., Matsuzaki, T., Liao, Y., Okuda, K., Yamato, M., Tsuchida, S., Araki, R., Asano, Y., Asanuma, H., Asakura, M., French, B., Sakata, Y., Kitakaze, M. and Minamino, T.J.C.r., 2016. Chemical Endoplasmic Reticulum Chaperone Alleviates Doxorubicin-Induced Cardiac Dysfunction. 118, 798-809.
Gibb, A., Lorkiewicz, P., Zheng, Y., Zhang, X., Bhatnagar, A., Jones, S. and Hill, B.J.T.B.j., 2017. Integration of flux measurements to resolve changes in anabolic and catabolic metabolism in cardiac myocytes. 474, 2785-2801.
Gonano, L. and Vila Petroff, M.J.C.r., 2020. Direct Modulation of RyR2 Leading to a TRICky Ca Balance: The Effects of TRIC-A on Cardiac Muscle. 126, 436-438.
Haris, M., Singh, A., Cai, K., Kogan, F., McGarvey, J., Debrosse, C., Zsido, G., Witschey, W., Koomalsingh, K., Pilla, J., Chirinos, J., Ferrari, V., Gorman, J., Hariharan, H., Gorman, R. and Reddy, R.J.N.m., 2014. A technique for in vivo mapping of myocardial creatine kinase metabolism. 20, 209-14.
Hill, M. and Singal, P.J.C., 1997. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. 96, 2414-20.
Hoffman, J., Lyu, Y., Pletcher, S. and Promislow, D.J.E.i.b., 2017. Proteomics and metabolomics in ageing research: from biomarkers to systems biology. 61, 379-388.
Jiao, L., Zhang, H., Li, D., Yang, K., Tang, J., Li, X., Ji, J., Yu, Y., Wu, R., Ravichandran, S., Liu, J., Feng, G., Chen, M., Zeng, Y., Deng, R. and Zhu, X.J.A., 2018. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). 14, 671-684.
Kaplan, P., Babusikova, E., Lehotsky, J., Dobrota, D.J.M. and biochemistry, c., 2003. Free radical-induced protein modification and inhibition of Ca2+-ATPase of cardiac sarcoplasmic reticulum. 248, 41-7.
Kim, S., Abdelmegeed, M., Novak, R.J.T.J.o.p. and therapeutics, e., 2006. Identification of the insulin signaling cascade in the regulation of alpha-class glutathione S-transferase expression in primary cultured rat hepatocytes. 316, 1255-61.
Lu, S.J.B.e.b.a., 2013. Glutathione synthesis. 1830, 3143-53.
Ma, R., Ji, T., Zhang, H., Dong, W., Chen, X., Xu, P., Chen, D., Liang, X., Yin, X., Liu, Y., Ma, J., Tang, K., Zhang, Y., Peng, Y., Lu, J., Zhang, Y., Qin, X., Cao, X., Wan, Y. and Huang, B.J.N.c.b., 2018. A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8 T cells. 20, 21-27.
Marcinkiewicz-Siemion, M., Ciborowski, M., Ptaszynska-Kopczynska, K., Szpakowicz, A., Lisowska, A., Jasiewicz, M., Waszkiewicz, E., Kretowski, A., Musial, W., Kaminski, K.J.J.o.p. and analysis, b., 2018. LC-MS-based serum fingerprinting reveals significant dysregulation of phospholipids in chronic heart failure. 154, 354-363.
Marwick, T.J.J.o.n.m.o.p., Society of Nuclear Medicine, 2015. The role of echocardiography in heart failure. 31S-38S.
Mato, J., Martínez-Chantar, M. and Lu, S.J.H., 2014. Systems biology for hepatologists. 60, 736-43.
Maurer, M. and Packer, M.J.J.C.i., 2020. How Should Physicians Assess Myocardial Contraction?: Redefining Heart Failure With a Preserved Ejection Fraction. 13, 873-878.
Nguyen, T., Schwarzer, M., Schrepper, A., Amorim, P., Blum, D., Hain, C., Faerber, G., Haendeler, J., Altschmied, J. and Doenst, T.J.J.o.t.A.H.A., 2018. Increased Protein Tyrosine Phosphatase 1B (PTP1B) Activity and Cardiac Insulin Resistance Precede Mitochondrial and Contractile Dysfunction in Pressure-Overloaded Hearts. 7.
Ormazabal, P., Scazzocchio, B., Varì, R., Santangelo, C., D'Archivio, M., Silecchia, G., Iacovelli, A., Giovannini, C. and Masella, R.J.I.j.o.o., 2018. Effect of protocatechuic acid on insulin responsiveness and inflammation in visceral adipose tissue from obese individuals: possible role for PTP1B. 42, 2012-2021.
Owen, C., Lees, E., Grant, L., Zimmer, D., Mody, N., Bence, K. and Delibegović, M.J.D., 2013. Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice. 56, 2286-96.
Rayner, J., Peterzan, M., Watson, W., Clarke, W., Neubauer, S., Rodgers, C. and Rider, O.J.C., 2020. Myocardial Energetics in Obesity: Enhanced ATP Delivery Through Creatine Kinase With Blunted Stress Response. 141, 1152-1163.
Riehle, C. and Abel, E.J.C.r., 2016. Insulin Signaling and Heart Failure. 118, 1151-69.
Rinschen, M., Ivanisevic, J., Giera, M. and Siuzdak, G.J.N.r.M.c.b., 2019. Identification of bioactive metabolites using activity metabolomics. 20, 353-367.
Sliwa, K.J.E.h.j., 2020. Heart failure can affect everyone: the ESC Geoffrey Rose lecture. 41, 1298-1306.
Sueki, A., Stein, F., Savitski, M., Selkrig, J. and Typas, A.J.m., 2020. Systematic Localization of Escherichia coli Membrane Proteins. 5.
Suetomi, T., Yano, M., Uchinoumi, H., Fukuda, M., Hino, A., Ono, M., Xu, X., Tateishi, H., Okuda, S., Doi, M., Kobayashi, S., Ikeda, Y., Yamamoto, T., Ikemoto, N. and Matsuzaki, M.J.C., 2011. Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca²⁺release leading to catecholaminergic polymorphic ventricular tachycardia. 124, 682-94.
Sun Jang, J., Piao, S., Cha, Y., Kim, C.J.J.o.c.b. and nutrition, 2009. Taurine Chloramine Activates Nrf2, Increases HO-1 Expression and Protects Cells from Death Caused by Hydrogen Peroxide. 45, 37-43.
Tang, X., Pan, L., Zhao, S., Dai, F., Chao, M., Jiang, H., Li, X., Lin, Z., Huang, Z., Meng, G., Wang, C., Chen, C., Liu, J., Wang, X., Ferro, A., Wang, H., Chen, H., Gao, Y., Lu, Q., Xie, L., Han, Y. and Ji, Y.J.C., 2020. SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation. 141, 984-1000.
Tebay, L., Robertson, H., Durant, S., Vitale, S., Penning, T., Dinkova-Kostova, A., Hayes, J.J.F.r.b. and medicine, 2015. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. 88, 108-146.
Thiebaut, P., Besnier, M., Gomez, E., Richard, V.J.J.o.m. and cardiology, c., 2016. Role of protein tyrosine phosphatase 1B in cardiovascular diseases. 101, 50-57.
Turer, A., Altamirano, F., Schiattarella, G., May, H., Gillette, T., Malloy, C., Merritt, M.J.J.o.m. and cardiology, c., 2019. Remodeling of substrate consumption in the murine sTAC model of heart failure. 134, 144-153.
Wei, Y., Lu, M., Mei, M., Wang, H., Han, Z., Chen, M., Yao, H., Song, N., Ding, X., Ding, J., Xiao, M. and Hu, G.J.N.c., 2020. Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection. 11, 941.
Wolf, A., Agnihotri, S., Micallef, J., Mukherjee, J., Sabha, N., Cairns, R., Hawkins, C. and Guha, A.J.T.J.o.e.m., 2011. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. 208, 313-26.
Zhang, P., Guan, X., Yang, M., Zeng, L. and Liu, C.J.T.S.o.t.t.e., 2018. Roles and potential mechanisms of selenium in countering thyrotoxicity of DEHP. 732-739.
Zhang, X., Tian, J., Li, J., Huang, L., Wu, S., Liang, W., Zhong, L., Ye, J. and Ye, F.J.B.j.o.p., 2016. A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance. 173, 1939-49.
Zima, A., Mazurek, S.J.R.o.p., biochemistry and pharmacology, 2016. Functional Impact of Ryanodine Receptor Oxidation on Intracellular Calcium Regulation in the Heart. 171, 39-62.